To the full analysis
Ocular Therapeutix stock: growth
OCULOcular Therapeutix reported $51.82M in revenue for fiscal 2025, down 18.7% on the prior year, up 24.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
93.1%
per year from 2012 to 2025, per share 40.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2012 | |
|---|---|---|---|
| Revenue | 24.4% | 40.3% | 93.1% |
| Revenue per share | −0.7% | 13.9% | 40.3% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2012 | $10K | −$14.09M | −$12.79M |
| 2013 | $0 | −$13.32M | −$13.03M |
| 2014 | $772K | −$28.65M | −$21.76M |
| 2015 | $1.75M | −$39.75M | −$35.52M |
| 2016 | $1.89M | −$44.7M | −$35.92M |
| 2017 | $1.92M | −$63.39M | −$58.73M |
| 2018 | $1.99M | −$57.69M | −$51.12M |
| 2019 | $4.23M | −$86.37M | −$79.82M |
| 2020 | $17.4M | −$155.64M | −$54.4M |
| 2021 | $43.52M | −$6.55M | −$66.74M |
| 2022 | $51.49M | −$71.04M | −$63.32M |
| 2023 | $58.44M | −$80.74M | −$76.32M |
| 2024 | $63.72M | −$193.51M | −$135.97M |
| 2025 | $51.82M | −$265.94M | −$216.89M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 19 Dec 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.